Literature DB >> 10444461

Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension.

V Shah1, R Wiest, G Garcia-Cardena, G Cadelina, R J Groszmann, W C Sessa.   

Abstract

The molecular chaperone, heat shock protein 90 (Hsp90), acts as an intermediate in the signaling cascades leading to activation of endothelial nitric oxide synthase (eNOS). In this study, we examine the participation of this pathway in nitric oxide (NO)-dependent vasodilation in the rat mesentery in vitro. In normal animals, immunoprecipitation of eNOS from intact mesentery coimmunoprecipitates Hsp90 and, additionally, both eNOS and Hsp90 colocalize to the endothelial lining of mesenteric vessels. In the perfused mesenteric vasculature of normal animals, geldanamycin (GA), a specific inhibitor of Hsp90 signaling, attenuates ACh-dependent vasodilation but does not affect vasodilation in response to sodium nitroprusside. Next, studies were performed in animals with experimental portal hypertension induced by portal vein ligation (PVL). In PVL animals, NOS catalytic activity is markedly enhanced in mesenteric tissue and the perfused mesentery is hyporesponsive to the vasoconstrictor methoxamine (MTX). GA significantly potentiates MTX-induced vasoconstriction after PVL, thereby partially reversing the hyporeactivity to this agent exhibited in the mesenteric vasculature after PVL. These studies suggest that Hsp90 can act as a signaling mediator of NO-dependent responses in the mesenteric circulation and indicate that the excessive NO production observed in portal hypertension is mediated in part through Hsp90 signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444461     DOI: 10.1152/ajpgi.1999.277.2.G463

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

Review 2.  Current concepts on the role of nitric oxide in portal hypertension.

Authors:  Liang Shuo Hu; Jacob George; Jian Hua Wang
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

Review 3.  New cellular and molecular targets for the treatment of portal hypertension.

Authors:  Jordi Gracia-Sancho; Raquel Maeso-Díaz; Anabel Fernández-Iglesias; María Navarro-Zornoza; Jaime Bosch
Journal:  Hepatol Int       Date:  2015-03-05       Impact factor: 6.047

4.  Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension.

Authors:  Lukas Moleda; Lars Jurzik; Matthias Froh; Erwin Gäbele; Claus Hellerbrand; Rainer H Straub; Jürgen Schölmerich; Reiner Wiest
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

5.  Murine study of portal hypertension associated endothelin-1 hypo-response.

Authors:  Nicholas Theodorakis; Mary Maluccio; Nicholas Skill
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

6.  Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava.

Authors:  Chung S Lim; Xiaoying Qiao; Ossama M Reslan; Yin Xia; Joseph D Raffetto; Ewa Paleolog; Alun H Davies; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2010-11-23       Impact factor: 4.268

7.  Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo.

Authors:  M Bucci; F Roviezzo; C Cicala; W C Sessa; G Cirino
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

8.  Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction.

Authors:  Neetu Sud; Sandra M Wells; Shruti Sharma; Dean A Wiseman; Jason Wilham; Stephen M Black
Journal:  Am J Physiol Cell Physiol       Date:  2008-04-02       Impact factor: 4.249

9.  High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation.

Authors:  Brian G Drew; Noel H Fidge; Gabrielle Gallon-Beaumier; Bruce E Kemp; Bronwyn A Kingwell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

Review 10.  Endothelial nitric oxide (NO) and its pathophysiologic regulation.

Authors:  Anuran Chatterjee; Stephen M Black; John D Catravas
Journal:  Vascul Pharmacol       Date:  2008-07-20       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.